Registration is Now Open for RNA Therapeutics 2021
SMi Group are delighted to announce their 12th annual conference RNA Therapeutics, taking place on 10th - 11th February 2021.
London, United Kingdom, October 10, 2020 --(PR.com)-- The 2021 conference is set to explore the latest developments in RNA delivery agents and RNA-based therapeutics with the latest case studies on advanced mRNA technologies, oligonucleotide delivery, therapeutic applications and future trends and innovations.
New Addition To This Years Agenda
The 2021 programme includes the new Focus Day on the 12th February which focuses on RNA Interference. Chaired by Shalini Andersson, Chief Scientist New Therapeutic Modalities & Head of Oligonucleotide Discovery, AstraZeneca.
Panel discussion on COVID-19: how has the RNA industry adapted to beat the pandemic
Delegates stand to gain many valuable insights from this event such as:
• Industry insights into how mRNA is being used to combat COVID-19
• Case studies exploring the growing therapeutic potential of RNA for rare diseases
• Future trends in AI application for optimal RNA therapeutics
• A regulatory outlook of the RNA landscape, clinical trials and looking ahead
Visit the website for more details: www.therapeutics-rna.com/pcom1
Chair For 2021:
Heinrich Haas, VP RNA Formulation and Drug Delivery, BioNTech
Focus Day Chair for 2021: Shalini Andersson, Chief Scientist New Therapeutic Modalities & Head of Oligonucleotide Discovery, AstraZeneca
Key Speakers:
• Dong Yu, Fellow, Senior Director, and Head, GSK Vaccines
• Maria Luisa Pineda, CEO and Co-Founder, Envisagenics
• Kirsty Wydenbach, Deputy Unit Manager/Senior Medical Assessor, MHRA
• Dong Ki Lee, CEO, OliX
• Jennifer Pluim, Vice President Medical Affairs, ProQR
• Arpan Desai, Team Leader, Advanced Drug Delivery, Pharmaceutical Sciences, AstraZeneca
• Ruchi Shah, Senior Research Engineer, New Therapeutics Modalities, Eli Lilly and Company
• Michael Mulqueen, Vice President Business Development, eTheRNA immunotherapies
• Troels Koch, Founder & CEO, Aqiventa
Further details about the speakers can be found here: www.therapeutics-rna.com/prcom1
Proudly sponsored by: Thermo Fisher Scientific
Contact Information:
For media enquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: hsidhu@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
New Addition To This Years Agenda
The 2021 programme includes the new Focus Day on the 12th February which focuses on RNA Interference. Chaired by Shalini Andersson, Chief Scientist New Therapeutic Modalities & Head of Oligonucleotide Discovery, AstraZeneca.
Panel discussion on COVID-19: how has the RNA industry adapted to beat the pandemic
Delegates stand to gain many valuable insights from this event such as:
• Industry insights into how mRNA is being used to combat COVID-19
• Case studies exploring the growing therapeutic potential of RNA for rare diseases
• Future trends in AI application for optimal RNA therapeutics
• A regulatory outlook of the RNA landscape, clinical trials and looking ahead
Visit the website for more details: www.therapeutics-rna.com/pcom1
Chair For 2021:
Heinrich Haas, VP RNA Formulation and Drug Delivery, BioNTech
Focus Day Chair for 2021: Shalini Andersson, Chief Scientist New Therapeutic Modalities & Head of Oligonucleotide Discovery, AstraZeneca
Key Speakers:
• Dong Yu, Fellow, Senior Director, and Head, GSK Vaccines
• Maria Luisa Pineda, CEO and Co-Founder, Envisagenics
• Kirsty Wydenbach, Deputy Unit Manager/Senior Medical Assessor, MHRA
• Dong Ki Lee, CEO, OliX
• Jennifer Pluim, Vice President Medical Affairs, ProQR
• Arpan Desai, Team Leader, Advanced Drug Delivery, Pharmaceutical Sciences, AstraZeneca
• Ruchi Shah, Senior Research Engineer, New Therapeutics Modalities, Eli Lilly and Company
• Michael Mulqueen, Vice President Business Development, eTheRNA immunotherapies
• Troels Koch, Founder & CEO, Aqiventa
Further details about the speakers can be found here: www.therapeutics-rna.com/prcom1
Proudly sponsored by: Thermo Fisher Scientific
Contact Information:
For media enquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: hsidhu@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Jinna Sidhu
+44 (0) 20 7827 6088
http://www.therapeutics-rna.com/pcom1
Jinna Sidhu
+44 (0) 20 7827 6088
http://www.therapeutics-rna.com/pcom1
Contact
Categories